TherOx Completes Enrollment in Study of Next-Generation Therapy System Designed to Improve AMI Outcomes
Autor: | TherOx, Inc. |
---|---|
Zdroj: | Business Wire (English). 05/03/2017. |
Abstrakt: | TherOx, Inc., a privately held medical device company focused on improved treatment of Acute Myocardial Infarction (AMI), announced that it completed enrollment in the IC-HOT (Evaluation of Intracoronary Hyperoxemic Oxygen Therapy) study. IC-HOT is a confirmatory study of the second-generation TherOx system that delivers Supersaturated Oxygen (SSO2) Therapy for reduction of infarct size after an AMI. [ABSTRACT FROM PUBLISHER] |
Databáze: | Regional Business News |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |